Icelandic Biotech Alvotech Gets the Green Light

by | Jun 7, 2022

3 merger votes today. The usual extensions. And the rest of the day’s news in SPACs.

Free Investor Resources from Boardroom Alpha
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

OACB / Alvotech Approved

Oaktree Acquisition Corp. II (OACB) approves merger with Icelandic biotech Alvotech Holdings S.A. (ALVO). Expected close on or about June 15, 2022.

DWIN Extends

Delwinds Insurance Acquisition Corp. (DWIN) 9M shares redeemed (~45%). SPAC adds $0.035 / month deposit until 9/15. To merge with FOXO Technologies. We chatted with FOXO CEO Jon Sabes back in April. See the podcast here.

GACQ Extends

Global Consumer Acquisition Corp. (GACQ) gets first of two extensions to 9/11/2022. SPAC adds $0.10 to trust, ~$10.15 NAV.

VCKA Extends

Vickers Vantage Corp. I (VCKA) files for another extension to August (vote 6/30), and up to 5 more months without a vote to January. Adds $0.033 / month. DA with Scilex.

Symbotic Trades Tomorrow

AI-enabled robotics specialist Symbotic deSPACs tomorrow as SYM.

Elsewhere in SPACs

Other merger votes today

  • Globis Acquisition Corp. GLAQ / Forafric Agro Holdings
  • Dynamics Special Purpose Corp. DYNS / Senti Bio

Boardroom Alpha SPAC Market Review for May

Time is running out as SPACs scramble to finance deals at almost any cost. Expect more deSPAC duds as sponsors push low-quality companies at onerous valuations — for the simple purpose of protecting at-risk capital. Full report here.

SPAC Calendar

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – January 2023

It was a slower month to kick off the year for SPACs. In what stands to be a pivotal year for the future of the market, we recap January.

SPAC Market Review – December 2022

December’s SPAC market review takes a look by the numbers of the month’s SPAC activity and how the market currently stands going into 2023.

SPAC Research & Analysis

Boardroom Alpha Digest: Thurs, Mar 9

Biogen Inc. (BIIB) chairman Stelios Papadopoulos will not stand for reelection at the annual meeting, and other highlights of the day.

Boardroom Alpha Digest: Weds, Mar 1

Salesforce Inc. (CRM) surges after hours following earnings amidst potential activist activity and today’s SPAC, IPO, and Exec News.

Know Who Drives Return Podcast


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.